Literature DB >> 21647664

Studies of H4R antagonists using 3D-QSAR, molecular docking and molecular dynamics.

Jing Liu1, Yan Li, Hui-Xiao Zhang, Shu-Wei Zhang, Ling Yang.   

Abstract

Three-dimensional quantitative structure-activity relationship studies were performed on a series of 88 histamine receptor 4 (H4R) antagonists in an attempt to elucidate the 3D structural features required for activity. Several in silico modeling approaches, including comparative molecular field analysis (CoMFA), comparative similarity indices analysis (CoMSIA), molecular docking, and molecular dynamics (MD), were carried out. The results show that both the ligand-based CoMFA model (Q (2) = 0.548, R (ncv) (2)  = 0.870, R (pre) (2)  = 0.879, SEE = 0.410, SEP = 0.386) and the CoMSIA model (Q (2) = 0.526, R (ncv) (2) =0.866, R (pre) (2)  = 0.848, SEE = 0.416, SEP = 0.413) are acceptable, as they show good predictive capabilities. Furthermore, a combined analysis incorporating CoMFA, CoMSIA contour maps and MD results shows that (1) compounds with bulky or hydrophobic substituents at positions 4-6 in ring A (R2 substituent), positively charged or hydrogen-bonding (HB) donor groups in the R1 substituent, and hydrophilic or HB acceptor groups in ring C show enhanced biological activities, and (2) the key amino acids in the binding pocket are TRP67, LEU71, ASP94, TYR95, PHE263 and GLN266. To our best knowledge, this work is the first to report the 3D-QSAR modeling of these H4R antagonists. The conclusions of this work may lead to a better understanding of the mechanism of antagonism and aid in the design of new, more potent H4R antagonists.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21647664     DOI: 10.1007/s00894-011-1137-x

Source DB:  PubMed          Journal:  J Mol Model        ISSN: 0948-5023            Impact factor:   1.810


  32 in total

1.  The first potent and selective non-imidazole human histamine H4 receptor antagonists.

Authors:  Jill A Jablonowski; Cheryl A Grice; Wenying Chai; Curt A Dvorak; Jennifer D Venable; Annette K Kwok; Kiev S Ly; Jianmei Wei; Sherry M Baker; Pragnya J Desai; Wen Jiang; Sandy J Wilson; Robin L Thurmond; Lars Karlsson; James P Edwards; Timothy W Lovenberg; Nicholas I Carruthers
Journal:  J Med Chem       Date:  2003-09-11       Impact factor: 7.446

2.  Investigation on QSAR and binding mode of a new class of human rhinovirus-14 inhibitors by CoMFA and docking experiments.

Authors:  M Artico; M Botta; F Corelli; A Mai; S Massa; R Ragno
Journal:  Bioorg Med Chem       Date:  1996-10       Impact factor: 3.641

3.  A combined approach of docking and 3D QSAR study of beta-ketoacyl-acyl carrier protein synthase III (FabH) inhibitors.

Authors:  Ali Ashek; Seung Joo Cho
Journal:  Bioorg Med Chem       Date:  2005-11-04       Impact factor: 3.641

4.  Volume learning algorithm significantly improved PLS model for predicting the estrogenic activity of xenoestrogens.

Authors:  Vasyl V Kovalishyn; Vladyslav Kholodovych; Igor V Tetko; William J Welsh
Journal:  J Mol Graph Model       Date:  2007-03-19       Impact factor: 2.518

5.  Dynamic mechanism of E2020 binding to acetylcholinesterase: a steered molecular dynamics simulation.

Authors:  Chunying Niu; Yechun Xu; Yong Xu; Xiaomin Luo; Wenhu Duan; Israel Silman; Joel L Sussman; Weiliang Zhu; Kaixian Chen; Jianhua Shen; Hualiang Jiang
Journal:  J Phys Chem B       Date:  2005-12-15       Impact factor: 2.991

6.  Tn5 transposase as a useful platform to simulate HIV-1 integrase inhibitor binding mode.

Authors:  Maria Letizia Barreca; Francesco Ortuso; Nunzio Iraci; Laura De Luca; Stefano Alcaro; Alba Chimirri
Journal:  Biochem Biophys Res Commun       Date:  2007-09-14       Impact factor: 3.575

7.  Structure-activity studies on a series of a 2-aminopyrimidine-containing histamine H4 receptor ligands.

Authors:  Robert J Altenbach; Ronald M Adair; Brian M Bettencourt; Lawrence A Black; Shannon R Fix-Stenzel; Sujatha M Gopalakrishnan; Gin C Hsieh; Huaqing Liu; Kennan C Marsh; Michael J McPherson; Ivan Milicic; Thomas R Miller; Timothy A Vortherms; Usha Warrior; Jill M Wetter; Neil Wishart; David G Witte; Prisca Honore; Timothy A Esbenshade; Arthur A Hancock; Jorge D Brioni; Marlon D Cowart
Journal:  J Med Chem       Date:  2008-09-24       Impact factor: 7.446

8.  Binding mode analysis and enrichment studies on homology models of the human histamine H4 receptor.

Authors:  Róbert Kiss; Béla Noszál; Akos Rácz; András Falus; Dániel Eros; György M Keseru
Journal:  Eur J Med Chem       Date:  2007-08-06       Impact factor: 6.514

9.  Mechanism of microRNA-target interaction: molecular dynamics simulations and thermodynamics analysis.

Authors:  Yonghua Wang; Yan Li; Zhi Ma; Wei Yang; Chunzhi Ai
Journal:  PLoS Comput Biol       Date:  2010-07-29       Impact factor: 4.475

10.  In silico prediction of estrogen receptor subtype binding affinity and selectivity using statistical methods and molecular docking with 2-arylnaphthalenes and 2-arylquinolines.

Authors:  Zhizhong Wang; Yan Li; Chunzhi Ai; Yonghua Wang
Journal:  Int J Mol Sci       Date:  2010-09-20       Impact factor: 5.923

View more
  1 in total

1.  QSAR analysis of 3-pyrimidin-4-yl-oxazolidin-2-one derivatives isocitrate dehydrogenase inhibitors using Topomer CoMFA and HQSAR methods.

Authors:  Jian-Bo Tong; Shuai Bian; Xing Zhang; Ding Luo
Journal:  Mol Divers       Date:  2021-05-11       Impact factor: 2.943

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.